This new initiative brings together provider groups, purchasers and end users committed to evidence-based, cost-effective, equitable digital health solutions.
In a time where the demand for digital health technologies is needed, the Digital Health Collaborative, a new organization dedicated to advancing the evidence and adoption of digital health solutions, has gained support from 14 leading healthcare and consumer organizations.
© stock.adobe.com
Despite advancements in this space, purchasers are challenged with determining the best solutions for their digital health needs.
This new initiative brings together provider groups, purchasers and end users committed to evidence-based, cost-effective, equitable digital health solutions.
The Peterson Health Technology Institute (PHTI), an initiative of the Peterson Center on Healthcare, is a supporter of the Collaborative.
PHTI assesses digital health solutions to determine their clinical effectiveness and financial impact for purchasers like payers, providers, and employers on behalf of patients.
Meg Baron, managing director of engagement and outreach at PHTI shared with Managed Healthcare Executive, "Collaborative members will jointly work together on research, programs, and knowledge sharing to help raise purchaser confidence and adoption of digital health solutions. Initial activities will include a national survey of digital health purchasers, grantmaking through a Research and Impact Fund, and regular convenings, including at an annual Summit."
Collaborative members include:
Through support from PHTI, the Collaborative will offer the Research and Impact Fund for aligned research and programs.
The first grant was awarded to DiMe for its Integrated Evidence Plans for Digital Health Products project to help developers align digital health products with purchaser evidence requirements.
“With a growing market of digital health solutions available to providers and consumers, the Digital Health Collaborative will play an important role in helping to bring together the perspectives and voices across the health system to meaningfully share insights on new and emerging technology,” Danielle Lloyd, senior vice president of Private Market Innovations and Quality at AHIP, said. “We hope the Collaborative’s research, analysis and data initiatives can help fill important gaps in assessing clinical value and health outcomes for stakeholders across the health system.”
FDA Approves First At-Home Cervical Cancer Screening Device
May 15th 2025Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare barriers, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
The First Financial Toxicity Tumor Board Reports Success in Individual Patient Savings
May 14th 2025Financial toxicity can affect patient outcomes and quality of life. For example, a patient may forgo treatment or medications to save money, or they may incur high medical debt or go into bankruptcy to pay for medical care.
Read More